Orion Oyj banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
Finland FI
Employees
4 132
IPO date
Jul 3, 2006

Orion Oyj is a Finnish pharmaceutical company that develops, manufactures, and sells medicines for people and animals. Its main products include prescription drugs, over-the-counter medicines, and veterinary medicines, with a strong focus on treatments for the central nervous system, cancer care, and animal health. The company also makes active pharmaceutical ingredients and other drug-related products that it sells to partners in the healthcare industry.

Orion sells its products to pharmacies, hospitals, doctors, veterinarians, and other drug companies. It earns money mainly by selling branded medicines, generic medicines, and pharmaceutical ingredients, plus royalties and license income from drug development partnerships. In practice, Orion sits between research and the end market: it turns drug research and manufacturing know-how into finished medicines that can be sold under its own brands or by partners.

What makes Orion different is its mix of human health, animal health, and drug ingredient businesses under one roof. That gives it multiple ways to make money from the same scientific and manufacturing base, while reducing reliance on any single product line. For beginner investors, the key point is that Orion is not a broad healthcare company; it is a focused drug maker that competes through pharmaceutical research, regulatory expertise, and reliable production.

Orion Oyj Investor Relations

Address
Orionintie 1A
Espoo, Etela-Suomen
Finland

Business Segments

Human medicines

Orion develops and sells prescription and consumer medicines for people, including branded treatments and generic products in its main therapy areas.

Customers and revenue model

Animal health

This part of the business sells medicines for pets and farm animals.

Customers and revenue model

Pharmaceutical ingredients and production

Description, customers and revenue model

Management

Mr. Rene Lindell M.Sc., Ph.D.

Chief Financial Officer & Member of Group Executive Management Board

Biography unavailable

Mr. Olli Huotari Ll.M.

Senior VP of Corporate Functions, General Counsel, Secretary & Member of Executive Management Board

Biography unavailable

Ms. Satu Ahomäki M.Sc., M.Sc. (Econ.)

Senior VP of Generics and Consumer Health Business Division & Member of the Exe. Mgmt. Board

Biography unavailable

Prof. Outi Vaarala M.D., Ph.D.

Sr. VP of Innovative Medicines, Sr. VP of R&D and Member of the Exe. Mgmt. Board

Biography unavailable

Mr. Juhani Kankaanpaa

Senior VP of Global Operations & Member of Executive Management Board

Biography unavailable

Mr. Niclas Lindstedt EMBA, M.Sc.

Senior VP of Animal Health Business Division & Member of the Exe. Mgmt. Board

Biography unavailable

Mr. Hao Pan M.Sc.

Senior VP of the Branded Products Business Division & Member of the Exe. Mgmt. Board

Biography unavailable

Ms. Julia Irene Macharey

Senior Vice President of People & Culture and Member of Management Board

Biography unavailable

Mr. Tuukka Hirvonen M.Sc.(Soc.)

Investor Relations & Financial Communications Officer

Biography unavailable

Ms. Terhi Ormio

Vice President of Communications

Biography unavailable

1 / 10